skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Join Timothy Pang of Informa Pharma Consulting for this informative webinar. Timothy shares how Pharma Consulting works with you to produce actionable, flexible solutions tailored to your needs. Informa Pharma Consulting helps you discover new business opportunities, reduce risks, and make better, faster decisions.





  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート, Scrip: 世界の医療用医薬品&製薬...

    The tumor-agnostic developer’s toolkit

    By Daniel Chancellor

    The tumor-agnostic developer’s toolkit

  • Pharma consulting: 医療用医薬品のコンサルティング

    Custom Intelligence Biosimilars Report

    You’ve probably noticed that biosimilars are the growth engine in global medicine spending right now. You’re not alone. With biologics accounting for 20-22% of total pharmaceutical spending already and looking to grow to $320 bn in the US alone by 2023, more and more companies and looking to compete in this arena. Informa’s Biosimilars Insights and Analysis Service can bring you the market intelligence and insights to inform your decisions and help ensure you’re not missing out on opportunities.

    Topics Biosimilars

  • Pharma consulting: 医療用医薬品のコンサルティング

    Custom Intelligence Biosimilars Whitepaper

    If you’re looking at the opportunities to increase revenue and mitigate current and future threats by formulating the strongest biosimilars strategy, Informa’s Biosimilars Insights and Analysis Service is the tool you need.

    Topics Biosimilars






電話:+81 (0)3 6273 4260